高级检索
当前位置: 首页 > 详情页

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Sch Med, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China [2]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, 1111 XianXia Rd, Shanghai 200336, Peoples R China
出处:
ISSN:

关键词: SEER segmentectomy wedge resection non-small cell lung cancer survival

摘要:
Objectives: We performed this study to compare survival outcomes of segmentectomy (SG) and wedge resection (WR) in stage IA lung squamous cell carcinoma (SQCC) and lung adenocarcinoma (AD). Methods: Using the Surveillance, Epidemiology, and End Results registry (SEER), we identified 1529 and 4070 patients with stage IA SQCC and AD, respectively, who had complete clinical information between 2004 and 2015. We used Kaplan-Meier analysis to determine the propensity score for patients with limited resection based on the preoperative characteristics of patients. Lung cancer-specific survival (LCSS) was compared in patients treated with WR and SG after adjusting, stratifying, or matching lung cancer patients according to propensity score. Results: Kaplan-Meier analysis demonstrated that there was a statistically significant difference in survival curves (log rank P=0.01) for patients with stage IA SQCC between SG and WR. But there was no statistically significant difference in survival curves (log rank P>0.05) in patients with stage IA AD between the two limited resections. Compared with the WR, The hazard ratios (95% confidence intervals) of SG were 0.689 (0.519-0.914) and 0.896 (0.752-1.067) in patients with stage IA SQCC and AD, respectively. Conclusion: This study suggests that SG can yield superior survival outcome compared with WR in patients with stage IA SQCC. However, the survival outcomes of SG and WR are generally equivalent in patients with stage IA AD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Sch Med, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Sch Med, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China [*1]Department of Respiratory Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, No. 301, Yanchang Middle Road, Jing’an District, Shanghai 200072, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23453 今日访问量:6 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)